P149 Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis

C.M. Sloan; L.J. Sherrard; G.G.  Einarsson; M.M. Tunney; D.G. Downey

doi:10.1016/S1569-1993(21)01175-9

P149 Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis

C.M. Sloan, L.J. Sherrard, G.G. Einarsson, M.M. Tunney, D.G. Downey

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	P149
Pages (from-to)	S84-S85
Journal	Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Volume	20
Issue number	SUPPLEMENT 1
DOIs	https://doi.org/10.1016/S1569-1993(21)01175-9
Publication status	Published - 01 Jun 2021
Event	European Cystic Fibrosis Conference - Lyon, France Duration: 09 Jun 2021 → 12 Jun 2021

Access to Document

10.1016/S1569-1993(21)01175-9Licence: Unspecified

Cite this

Sloan, C. M., Sherrard, L. J., Einarsson, G. G., Tunney, M. M., & Downey, D. G. (2021). P149 Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 20(SUPPLEMENT 1), S84-S85. [P149]. https://doi.org/10.1016/S1569-1993(21)01175-9

Sloan, C.M. ; Sherrard, L.J. ; Einarsson, G.G. ; Tunney, M.M. ; Downey, D.G. / P149 Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis. In: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 2021 ; Vol. 20, No. SUPPLEMENT 1. pp. S84-S85.

@article{bc00e7f6a7ed41d4b242444cfdfa64b6,

title = "P149 Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis",

author = "C.M. Sloan and L.J. Sherrard and G.G. Einarsson and M.M. Tunney and D.G. Downey",

year = "2021",

month = jun,

day = "1",

doi = "10.1016/S1569-1993(21)01175-9",

language = "English",

volume = "20",

pages = "S84--S85",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier Inc.",

number = "SUPPLEMENT 1",

note = "European Cystic Fibrosis Conference ; Conference date: 09-06-2021 Through 12-06-2021",

}

Sloan, CM , Sherrard, LJ , Einarsson, GG , Tunney, MM & Downey, DG 2021, 'P149 Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis', Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, vol. 20, no. SUPPLEMENT 1, P149, pp. S84-S85. https://doi.org/10.1016/S1569-1993(21)01175-9

P149 Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis. / Sloan, C.M.; Sherrard, L.J.; Einarsson, G.G. ; Tunney, M.M.; Downey, D.G.

In: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, Vol. 20, No. SUPPLEMENT 1, P149, 01.06.2021, p. S84-S85.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - P149 Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis

AU - Sloan, C.M.

AU - Sherrard, L.J.

AU - Einarsson, G.G.

AU - Tunney, M.M.

AU - Downey, D.G.

PY - 2021/6/1

Y1 - 2021/6/1

U2 - 10.1016/S1569-1993(21)01175-9

DO - 10.1016/S1569-1993(21)01175-9

M3 - Meeting abstract

VL - 20

SP - S84-S85

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

SN - 1569-1993

IS - SUPPLEMENT 1

M1 - P149

T2 - European Cystic Fibrosis Conference

Y2 - 9 June 2021 through 12 June 2021

ER -

Sloan CM , Sherrard LJ , Einarsson GG , Tunney MM , Downey DG. P149 Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 2021 Jun 1;20(SUPPLEMENT 1):S84-S85. P149. https://doi.org/10.1016/S1569-1993(21)01175-9